COVID-19 FSD Pharma forfeits cannabis licences to focus on Covid-19 treatments, firm says Shares rose 12.5% as the company shared plans to liquidate $12.3M worth of weed-related assets Jared GnamJuly 30, 2020
The weed wire FSD Pharma scales back cultivation, implements furlough The cutback excludes staff working staggered shifts to ensure operations continuity and procedures necessary to maintain licensing Nick LabaMarch 23, 2020